Skip to main content

Table 1 Summary of stakeholder involvement

From: Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

Key stakeholders
Physicians (including dermatologists, international providers, physicians of other health care fields)
Patients
Drug and device safety regulators (e.g., FDA, EMA)
Pharmacologists/pharmacists
Industry scientists
Nurses, physician assistants, or other health care providers
  1. EMA European Medicines Agency, FDA U.S. Food and Drug Administration